274 related articles for article (PubMed ID: 30142110)
41. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation.
Morgan JA; Stewart AS; Lee BJ; Oz MC; Naka Y
ASAIO J; 2004; 50(4):360-3. PubMed ID: 15307548
[TBL] [Abstract][Full Text] [Related]
42. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
[TBL] [Abstract][Full Text] [Related]
43. Acute intraventricular thrombosis of an impella LP 5.0 device in an ST-elevated myocardial infarction complicated by cardiogenic shock.
Ranc S; Sibellas F; Green L
J Invasive Cardiol; 2013 Jan; 25(1):E1-3. PubMed ID: 23293180
[TBL] [Abstract][Full Text] [Related]
44. Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival.
Esposito ML; Jablonski J; Kras A; Krasney S; Kapur NK
Int J Artif Organs; 2018 Apr; 41(4):236-239. PubMed ID: 29637832
[TBL] [Abstract][Full Text] [Related]
45. Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction.
Anderson M; Smedira N; Samuels L; Madani M; Naka Y; Acker M; Hout M; Benali K
Ann Thorac Surg; 2010 Sep; 90(3):706-12. PubMed ID: 20732481
[TBL] [Abstract][Full Text] [Related]
46. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
Meyns B; Dens J; Sergeant P; Herijgers P; Daenen W; Flameng W
Thorac Cardiovasc Surg; 2003 Dec; 51(6):312-7. PubMed ID: 14669126
[TBL] [Abstract][Full Text] [Related]
47. Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality.
Schroeter MR; Köhler H; Wachter A; Bleckmann A; Hasenfuß G; Schillinger W
J Invasive Cardiol; 2016 Dec; 28(12):467-472. PubMed ID: 27529657
[TBL] [Abstract][Full Text] [Related]
48. Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis.
Vargas KG; Jäger B; Kaufmann CC; Biagioli A; Watremez S; Gatto F; Özbek C; Razouk A; Geppert A; Huber K
Wien Klin Wochenschr; 2020 Dec; 132(23-24):716-725. PubMed ID: 32691215
[TBL] [Abstract][Full Text] [Related]
49. Temporary mechanical circulatory support with Impella in cardiac surgery: A systematic review.
Pieri M; D'Andria Ursoleo J; Nardelli P; Ortalda A; Ajello S; Delrio S; Fominskiy E; Scandroglio AM
Int J Cardiol; 2024 Feb; 396():131418. PubMed ID: 37813286
[TBL] [Abstract][Full Text] [Related]
50. Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest.
Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Dersch W; Betz S; Ploeger B; Boesl E; O'Neill W; Kill C; Schieffer B
Resuscitation; 2018 May; 126():104-110. PubMed ID: 29522829
[TBL] [Abstract][Full Text] [Related]
51. Early Outcomes of the First 200 US Patients Treated with Impella 5.5: A Novel Temporary Left Ventricular Assist Device.
Ramzy D; Anderson M; Batsides G; Ono M; Silvestry S; D'Alessandro DA; Funamoto M; Zias EA; Lemaire A; Soltese E
Innovations (Phila); 2021; 16(4):365-372. PubMed ID: 34101514
[TBL] [Abstract][Full Text] [Related]
52. Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices.
DeRose JJ; Umana JP; Argenziano M; Catanese KA; Levin HR; Sun BC; Rose EA; Oz MC
Ann Thorac Surg; 1997 Dec; 64(6):1757-62; discussion 1762-3. PubMed ID: 9436568
[TBL] [Abstract][Full Text] [Related]
53. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
[TBL] [Abstract][Full Text] [Related]
54. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
[TBL] [Abstract][Full Text] [Related]
55. Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock.
Sugimura Y; Immohr MB; Mehdiani A; Boeken U; Aubin H; Lichtenberg A; Akhyari P
Ann Thorac Cardiovasc Surg; 2024 Jan; 30(1):. PubMed ID: 37532525
[TBL] [Abstract][Full Text] [Related]
56. Distal Embolic Protection in Impella 5.0 Explantation: Loop and Snare Technique.
Kawabori M; Pramil V; Shindgikar P; Zhan Y; Warner KG; Rastegar H; Kapur NK; Chen FY; Couper GS
Ann Thorac Surg; 2020 Feb; 109(2):e145-e146. PubMed ID: 31563488
[TBL] [Abstract][Full Text] [Related]
57. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.
Pieri M; Contri R; Winterton D; Montorfano M; Colombo A; Zangrillo A; De Bonis M; Pappalardo F
BMC Cardiovasc Disord; 2015 Oct; 15():126. PubMed ID: 26466899
[TBL] [Abstract][Full Text] [Related]
58. Improved survival with ventricular assist device support in cardiogenic shock after myocardial infarction.
Entwistle JW; Bolno PB; Holmes E; Samuels LE
Heart Surg Forum; 2003; 6(5):316-9. PubMed ID: 14721801
[TBL] [Abstract][Full Text] [Related]
59. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany.
Bernhardt AM; Potapov E; Schibilsky D; Ruhparwar A; Tschöpe C; Spillmann F; Benk C; Schmack B; Schmitto JD; Napp LC; Mayer-Wingert N; Doll N; Reichenspurner H; Schulte-Eistrup S
J Heart Lung Transplant; 2021 Aug; 40(8):850-855. PubMed ID: 34030970
[TBL] [Abstract][Full Text] [Related]
60. Reconsidering FDA Guidelines: A Single-Center Experience of Prolonged Impella 5.5 Support.
Valdes CA; Stinson G; Sharaf OM; Jimenez Contreras F; Bilgili A; Ahmed MM; Vilaro J; Parker AM; Al-Ani MAZ; Demos D; Aranda J; Bleiweis M; Beaver TM; Jeng EI
Innovations (Phila); 2024; 19(1):46-53. PubMed ID: 38013250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
